Imagion Biosystems Ltd IBX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.08
- Day Range
- A$0.07–0.08
- 52-Week Range
- A$0.07–1.44
- Bid/Ask
- A$0.00 / A$0.00
- Market Cap
- A$2.42 Mil
- Volume/Avg
- 13,188 / 75,280
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.37
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- —
Valuation
Metric
|
IBX
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1.37 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
IBX
|
---|---|
Quick Ratio | 0.16 |
Current Ratio | 0.27 |
Interest Coverage | — |
Quick Ratio
IBX
Profitability
Metric
|
IBX
|
---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
IBX
Diagnostics & Research Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Pgwfyszlcw | Yprv | $209.3 Bil | |
DHR
| Danaher Corp | Wwxgfwtxtd | Wctnv | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Xtcxwbmhw | Bwdjmy | $42.8 Bil | |
IDXX
| IDEXX Laboratories Inc | Rcdvzcbl | Hwvnqgy | $41.5 Bil | |
A
| Agilent Technologies Inc | Ckxmykjhw | Vfv | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Gmspdsjhvq | Mxvjkz | $26.5 Bil | |
ICLR
| Icon PLC | Smyxyglz | Cdmbnj | $24.8 Bil | |
ILMN
| Illumina Inc | Jypzsmvd | Tkbtdp | $19.5 Bil | |
WAT
| Waters Corp | Rjykvgkyl | Lgr | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Vtmzwsmvf | Cmmcsj | $16.7 Bil |